US/Canada Revenue Share

Why it matters for underwriting

The United States and Canada are treated as a distinct exposure band in liability underwriting because their tort systems combine jury trials, punitive damages, contingency-fee litigation and, in the US, extensive class-action mechanisms that can produce awards several multiples higher than comparable claims in Europe or Switzerland. Even a modest share of revenue generated in or attributable to these markets can dominate the severity profile of an otherwise moderate liability account, particularly for product manufacturers whose goods reach US or Canadian end users through any part of the supply chain, including through a European distributor that re-exports without the manufacturer’s direct knowledge. Umbrella and excess layers are especially sensitive to this exposure, since a single large US verdict can exhaust primary limits and reach directly into excess layers that were priced assuming a much lower loss frequency. Underwriters need this figure, tracked separately from the overall export share, to decide whether US/Canada exposure can be underwritten within the standard programme, priced at a loaded rate, or requires distinct capacity, wording and reinsurance treatment.

Capturing the attribute and evidence

Proposal forms ask for the percentage of turnover generated in or attributable to the US and Canada and how that exposure arises, whether through direct sales, a local subsidiary, or independent distributors and agents who may reduce, redirect or duplicate primary liability depending on the terms of the distribution agreement. Underwriters verify the declared figure against the revenue breakdown by country, distribution or subsidiary agreements, and the insured’s prior claims history in these jurisdictions, paying close attention to any growth trend, new product launches aimed at the North American market, or pending litigation that has not yet translated into a formal claim. Where the insured cannot readily separate US/Canada revenue from broader export figures, underwriters typically treat the uncertainty itself as an aggravating factor and request a more conservative estimate.

Effect on coverage, premium and conditions

A low or nil US/Canada revenue share generally allows standard liability terms to apply without adjustment, since the account’s severity profile remains anchored to more predictable home-market litigation patterns. A material or growing share typically triggers premium loading calculated on a per-unit or per-dollar-of-US-revenue basis, a dedicated US/Canada sublimit or aggregate that caps the insurer’s exposure independently of the overall policy limit, exclusionary wording for US/Canada products or completed-operations liability unless specifically bought back at additional premium, and conditions requiring enhanced disclosure of distribution structures, indemnification arrangements with local partners, and any changes in US/Canada sales volume during the policy period. Umbrella and excess placements are typically structured with their own US/Canada terms, since the primary layer’s treatment of this exposure does not automatically flow through to layers negotiated with different reinsurers.

Mitigation measures

Insureds with growing North American exposure are generally advised to review and strengthen indemnification and insurance requirements in distributor and subsidiary agreements so that local partners carry an appropriate share of the risk, consider dedicated US/Canada liability capacity where the domestic programme excludes or sublimits this exposure, and notify insurers promptly of material changes in US/Canada sales volume or structure rather than waiting for renewal. Maintaining accurate, auditable revenue segmentation by destination market also allows the insured to demonstrate control over the exposure and supports a more favourable negotiation of sublimits and pricing at each renewal. Insureds should also track how goods reach North America indirectly, for example through European distributors who re-export without informing the manufacturer, since this hidden exposure is often the hardest for underwriters to price accurately.